Cerebral palsy

Lancet

Volumn 363, Issue 9421, 2004, Pages 1619-1631

  Koman, L Andrew ^a   Smith, Beth Paterson ^a   Shilt, Jeffrey S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALCOHOL; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; BACLOFEN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; DIAZEPAM; MUSCLE RELAXANT AGENT; NEUROMUSCULAR BLOCKING AGENT; PHENOL; TIZANIDINE;

ALLERGIC REACTION; BODY POSTURE; CEREBRAL PALSY; CHILDHOOD DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; ECHOGRAPHY; FATIGUE; FLU LIKE SYNDROME; HUMAN; HYPERBARIC OXYGEN; INFECTION; INJECTION PAIN; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MUSCLE CONTRACTURE; MUSCLE WEAKNESS; MYOFIBROSIS; NERVOUS SYSTEM; NEURECTOMY; NEUROMUSCULAR BLOCKING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL THERAPY; ORTHOPEDIC SURGERY; ORTHOTICS; PHYSIOTHERAPY; PRIORITY JOURNAL; PROTEIN DENATURATION; QUALITY OF LIFE; RASH; RHIZOTOMY; SIDE EFFECT; SPASTICITY; SPEECH THERAPY; SPINE MALFORMATION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 2442610030     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16207-7     Document Type: Conference Paper

References (190)

1. Kuban KC, Leviton A. Cerebral palsy. N Engl J Med. 330:1994;188-195
2. Boyle CA, Yeargin-Allsopp M, Doernberg NS, Holmgreen P, Murphy CC, Schendel DE. Prevalence of selected developmental disabilities in children 3-10 years of age: the Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1991. Morb Mortal Wkly Rep CDC Surveill Summ. 45:1996;1-14
3. Stanley E, Blair E, Alberman E. How common are the cerebral palsies? In: Cerebral palsies: epidemiology and causal pathways. London: MacKeith Press, 2000: 22-39.
4. Rumeau-Rouquette C, Grandjean H, Cans C, du MC, Verrier A. Prevalence and time trends of disabilities in school-age children. Int J Epidemiol. 26:1997;137-145
5. Koman LA, Smith BP, Balkrishnan R. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin. Paediatr Drugs. 5:2003;11-23
6. Cans C. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Dev Med Child Neurol. 42:2000;816-824
7. Paneth N. Etiologic factors in cerebral palsy. Pediatr Ann 1986; 15: 191, 194-95, 197-201.
8. O'Shea TM, Preisser JS, Klinepeter KL, Dillard RG. Trends in mortality and cerebral palsy in a geographically based cohort of very low birth weight neonates born between 1982 to 1994. Pediatrics. 101:1998;642-647
9. Blickstein I. Cerebral palsy in multifoetal pregnancies. Dev Med Child Neurol. 44:2002;352-355
10. Nelson KB, Grether JK. Causes of cerebral palsy. Curr Opin Pediatr. 11:1999;487-491
11. Nelson KB, Willoughby RE. Infection, inflammation and the risk of cerebral palsy. Curr Opin Neurol. 13:2000;133-139
12. Strauss D, Shavelle R. Life expectancy of adults with cerebral palsy. Dev Med Child Neurol. 40:1998;369-375
13. Hutton JL, Pharoah PO. Effects of cognitive, motor, and sensory disabilities on survival in cerebral palsy. Arch Dis Child. 86:2002;84-89
14. Kennes J, Rosenbaum P, Hanna SE, et al. Health status of school-aged children with cerebral palsy: information from a population-based sample. Dev Med Child Neurol. 44:2002;240-247
15. Rumeau-Rouquette C, du MC, Mlika A, Dequae L. Motor disability in children in three birth cohorts. Int J Epidemiol. 21:1992;359-366
16. Van Heest AE, House J, Putnam M. Sensibility deficiencies in the hands of children with spastic hemiplegia. J Hand Surg [Am] 1993; 18: 278-81.
17. Beckung E, Hagberg G. Neuroimpairments, activity limitations, and participation restrictions in children with cerebral palsy. Dev Med Child Neurol. 44:2002;309-316
18. Stiers P, Vanderkelen R, Vanneste G, Coene S, De Rammelaere M, Vandenbussche E. Visual-perceptual impairment in a random sample of children with cerebral palsy. Dev Med Child Neurol. 44:2002;370-382
19. Evans P, Elliott M, Alberman E, Evans S. Prevalence and disabilities in 4 to 8 year olds with cerebral palsy. Arch Dis Child. 60:1985;940-945
20. Boyle CA, Decoufle P, Yeargin-Allsopp M. Prevalence and health impact of developmental disabilities in US children. Pediatrics. 93:1994;399-403
21. Roijen LE, Postema K, Limbeek VJ, Kuppevelt VH. Development of bladder control in children and adolescents with cerebral palsy. Dev Med Child Neurol. 43:2001;103-107
22. Dabney KW, Lipton GE, Miller F. Cerebral palsy. Curr Opin Pediatr. 9:1997;81-88
23. Flett PJ. Rehabilitation of spasticity and related problems in childhood cerebral palsy. J Paediatr Child Health. 39:2003;6-14
24. Essex C. Hyperbaric oxygen and cerebral palsy: no proven benefit and potentially harmful. Dev Med Child Neurol. 45:2003;213-215
25. Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci. 21:2001;1302-1312
26. Dammann O, Leviton A. Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr. 12:2000;99-104
27. Eklind S, Mallard C, Leverin AL, et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur J Neurosci. 13:2001;1101-1106
28. Foster-Barber A, Dickens B, Ferriero DM. Human perinatal asphyxia: correlation of neonatal cytokines with MRI and outcome. Dev Neurosci. 23:2001;213-218
29. Gaudet LM, Smith GN. Cerebral palsy and chorioamnionitis: the inflammatory cytokine link. Obstet Gynecol Surv. 56:2001;433-436
30. Ness JK, Romanko MJ, Rothstein RP, Wood TL, Levison SW. Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors. Dev Neurosci. 23:2001;203-208
31. Schendel DE. Infection in pregnancy and cerebral palsy. J Am Med Womens Assoc. 56:2001;105-108
32. Goldstein EM. Spasticity management: an overview. J Child Neurol. 16:2001;16-23
33. Sanger TD, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW. Classification and definition of disorders causing hypertonia in childhood, Pediatrics 2003; 111: e89-e97 (abstr).
34. Fedrizzi E, Pagliano E, Andreucci E, Oleari G. Hand function in children with hemiplegic cerebral palsy: prospective follow-up and functional outcome in adolescence. Dev Med Child Neurol. 45:2003;85-91
35. Ingram TTS. A historical view of the definition and classification of the cerebral palsies. In: Stanley F, Alberman, eds. The epidemiology of the cerebral palsies. Philadelphia: JB Lippincott, 1984: 1-12.
36. Bleck EE. Orthopaedic management in cerebral palsy. 1987;JB Lippincott, Philadelphia
37. Hagberg B, Hagberg G, Olow I. The changing panorama of cerebral palsy in Sweden: VI, prevalence and origin during the birth year period 1983-1986. Acta Paediatr. 82:1993;387-393
38. Pharoah PO, Cooke T, Cooke RW, Rosenbloom L. Birthweight specific trends in cerebral palsy. Arch Dis Child. 65:1990;602-606
39. Stanley FJ, Watson L. Trends in perinatal mortality and cerebral palsy in Western Australia. BMJ. 304:1992;1658-1667
40. An evaluation of cerebral palsy data for epidemological studies: Ontario, 1996-2001. Ontario: Central West Health Planning Information Network, 2002.
41. McCarthy ML, Silberstein CE, Atkins EA, Harryman SE, Sponseller PD, Hadley-Miller NA. Comparing reliability and validity of pediatric instruments for measuring health and well-being of children with spastic cerebral palsy. Dev Med Child Neurol. 44:2002;468-476
42. Feldman AB, Haley SM, Coryell J. Concurrent and construct validity of the Pediatric Evaluation of Disability Inventory. Phys Ther. 70:1990;602-610
43. Msall ME, DiGaudio K, Rogers BT, et al. The Functional Independence Measure for Children (WeeFIM): conceptual basis and pilot use in children with developmental disabilities. Clin Pediatr. 33:1994;421-430
44. Johnson LM, Randall MJ, Reddihough DS, Oke LE, Byrt TA, Bach TM. Development of a clinical assessment of quality of movement for unilateral upper-limb function. Dev Med Child Neurol. 36:1994;965-973
45. DeMatteo C, Law M, Russell D, Pollock N, Rosenbaum P, Walter S. QUEST Quality of Upper Extremity Skills Test Manual. Neurodevelopmental Research Unit, McMaster University, Canada: 1992.
46. House JH, Gwathmey FW, Fidler MO. A dynamic approach to the thumb-in-palm deformity in cerebral palsy. J Bone Joint Surg. 63A:1981;216-225
47. Russell DJ, Avery LM, Rosenbaum PL, Raina PS, Walter SD, Palisano RJ. Improved scaling of the gross motor function measure for children with cerebral palsy: evidence of reliability and validity. Phys Ther. 80:2000;873-885
48. Boyce WF, Gowland C, Rosenbaum PL, et al. The gross motor performance measure: validity and responsiveness of a measure of quality of movement. Phys Ther. 75:1995;603-613
49. Palisano RJ, Hanna SE, Rosenbaum PL, et al. Validation of a model of gross motor function for children with cerebral palsy. Phys Ther. 80:2000;974-985
50. Corry IS, Cosgrove AP, Duffy CM. Botulinum toxin A as an alternative to serial casting in the conservative management of equinus in cerebral palsy. Dev Med Child Neurol. 37:1995;20-21
51. Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol. 36:1994;386-396
52. Koman LA, Mooney JF III, Smith BP, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop. 14:1994;299-303
53. Mackey AH, Lobb GL, Walt SE, Stott NS. Reliability and validity of the Observational Gait Scale in children with spastic diplegia. Dev Med Child Neurol. 45:2003;4-11
54. Ketelaar M, Vermeer A, Helders PJ. Functional motor abilities of children with cerebral palsy: a systematic literature review of assessment measures. Clin Rehabil. 12:1998;369-380
55. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner. 192:1964;540-542
56. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 67:1987;206-207
57. Tardieu G, Shentoub S, Delarue R. A la recherche d'une technique de mesure de la spasticité Neurologique. 91:1954;143-144
58. Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol. 6:1999;S23-S35
59. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology. 35:1985;73-77
60. Barry MJ, VanSwearingen JM, Albright AL. Reliability and responsiveness of the Barry-Albright Dystonia Scale. Dev Med Child Neurol. 41:1999;404-411
61. Andresen EM, Meyers AR. Health-related quality of life outcomes measures. Arch Phys Med Rehabil. 81:(suppl 2):2000;S30-S45
62. Wright JG, McLeod RS, Lossing A, Walters BC, Hu X. Measurement in surgical clinical research. Surgery. 119:1996;241-244
63. Landgraf JM, Abetz I, Ware JE. The Child Health Questionnaire user's manual, 1st edn. The Health Institute, New England Medical Center: 1996.
64. Daltroy LH, Liang MH, Fossel AH, Goldberg MJ. The POSNA pediatric musculoskeletal functional health questionnaire: report on reliability, validity, and sensitivity to change. J Pediatr Orthop. 18:1998;561-571
65. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 39:2001;800-812
66. Schneider JW, Gurucharri LM, Gutierrez AL, Gaebler-Spira DJ. Health-related quality of life and functional outcome measures for children with cerebral palsy. Dev Med Child Neurol. 43:2001;601-608
67. Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med. 33:2001;375-384
68. O'Brien CF. Treatment of spasticity with botulinum toxin. Clin J Pain. 18 (suppl):2002;S182-S190
69. Graham HK, Aoki KR, Autti-Rämö I, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture. 11:2000;67-79
70. Koman LA, Smith BP, Barron R. Recurrence of equinus foot deformity in cerebral palsy patients following surgery: a review. J South Orthop Assoc. 12:2003;1-9
71. Bower E, Michell D, Burnett M, Campbell MJ, McLellan DL. Randomized controlled trial of physiotherapy in 56 children with cerebral palsy followed for 18 months. Dev Med Child Neurol. 43:2001;4-15
72. Butler C, Darrah J. Effects of neurodevelopmental treatment (NDT) for cerebral palsy: an AACPDM evidence report. Dev Med Child Neurol. 43:2001;778-790
73. Palmer FB, Shapiro BK, Wachtel RC, et al. The effects of physical therapy on cerebral palsy: a controlled trial in infants with spastic diplegia. N Engl J Med. 318:1988;803-808
74. Damiano DL, Dodd K, Taylor NF. Should we be testing and training muscle strength in cerebral palsy? Dev Med Child Neurol. 44:2002;68-72
75. Bobath B. The treatment of neuromuscular disorders by improving patterns of co-ordination. Physiotherapy. 55:1969;18-22
76. Knox V, Evans AL. Evaluation of the functional effects of a course of Bobath therapy in children with cerebral palsy: a preliminary study. Dev Med Child Neurol. 44:2002;447-460
77. Doman RJ, Spitz EB, Zucman E, Delacato C, Doman G. Children with severe brain injuries: neurological organization in terms of mobility. JAMA. 174:1960;257-262
78. Reddihough DS, King J, Coleman G, Catanese T. Efficacy of programmes based on conductive education for young children with cerebral palsy. Dev Med Child Neurol. 40:1998;763-770
79. Sterba JA, Rogers BT, France AP, Vokes DA. Horseback riding in children with cerebral palsy: effect on gross motor function. Dev Med Child Neurol. 44:2002;301-308
80. Hutzler Y, Chacham A, Bergman U, Szeinberg A. Effects of a movement and swimming program on vital capacity and water orientation skills of children with cerebral palsy. Dev Med Child Neurol. 40:1998;176-181
81. Barry MJ. Physical therapy interventions for patients with movement disorders due to cerebral palsy. J Child Neurol. 11:1996;S51-S60
82. Stewart K. Massage for children with cerebral palsy. Nurs Times. 96:2000;50-51
83. Semenova KA. Basis for a method of dynamic proprioceptive correction in the restorative treatment of patients with residual-stage infantile cerebral palsy. Neurosci Behav Physiol. 27:1997;639-643
84. Charles J, Lavinder G, Gordon AM. Effects of constraint-induced therapy on hand function in children with hemiplegic cerebral palsy. Pediatr Phys Ther. 13:2001;68-76
85. Taub E, Morris DM. Constraint-induced movement therapy to enhance recovery after stroke. Curr Atheroscler Rep. 3:2001;279-286
86. Crocker MD, MacKay-Lyons M, McDonnell E. Forced use of the upper extremity in cerebral palsy: a single-case design. Am J Occup Ther. 51:1997;824-833
87. Pierce SR, Daly K, Gallagher KG, Gershkoff AM, Schaumburg SW. Constraint-induced therapy for a child with hemiplegic cerebral palsy: a case report. Arch Phys Med Rehabil. 83:2002;1462-1463
88. Willis JK, Morello A, Davie A, Rice JC, Bennett JT. Forced use treatment of childhood hemiparesis. Pediatrics. 110:2002;94-96
89. Pape KE, Kirsch SE, Galil A, Boulton JE, White MA, Chipman M. Neuromuscular approach to the motor deficits of cerebral palsy: a pilot study. J Pediatr Orthop. 13:1993;628-633
90. Carmick J. Clinical use of neuromuscular electrical stimulation for children with cerebral palsy, part 1. Phys Ther. 73:1993;505-513
91. Dali C, Hansen FJ, Pedersen SA, et al. Threshold electrical stimulation (TES) in ambulant children with CP: a randomized double-blind placebo-controlled clinical trial. Dev Med Child Neurol. 44:2002;364-369
92. Sommerfelt K, Markestad T, Berg K, Saetesdal I. Therapeutic electrical stimulation in cerebral palsy: a randomized, controlled, crossover trial. Dev Med Child Neurol. 43:2001;609-613
93. Scheker LR, Chesher SP, Ramirez S. Neuromuscular electrical stimulation and dynamic bracing as a treatment for upper-extremity spasticity in children with cerebral palsy. J Hand Surg [Br]. 24:1999;226-232
94. Hesse S, Jahnke MT, Luecke D, Mauritz KH. Short-term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett. 201:1995;37-40
95. Buckon CE, Thomas SS, Jakobson-Huston S, Moor M, Sussman M, Aiona M. Comparison of three ankle-foot orthosis configurations for children with spastic hemiplegia. Dev Med Child Neurol. 43:2001;371-378
96. Crenshaw S, Herzog R, Castagno P, et al. The efficacy of tone-reducing features in orthotics on the gait of children with spastic diplegic cerebral palsy. J Pediatr Orthop. 20:2000;210-216
97. Miller A, Temple T, Miller F. Impact of orthoses on the rate of scoliosis progression in children with cerebral palsy. J Pediatr Orthop. 16:1996;332-335
98. Letts M, Rathbone D, Yamashita T, Nichol B, Keeler A. Soft Boston orthosis in management of neuromuscular scoliosis: a preliminary report. J Pediatr Orthop. 12:1992;470-474
99. Olafsson Y, Saraste H, Al Dabbagh Z. Brace treatment in neuromuscular spine deformity. J Pediatr Orthop. 19:1999;376-379
100. Renshaw TS, Green NE, Griffin PP, Root L. Cerebral palsy: orthopaedic management. J Bone Joint Surg. 77A:1995;1590-1606
101. Collet JP, Vanasse M, Marois P, et al. Hyperbaric oxygen for children with cerebral palsy: a randomised multicentre trial. Lancet. 357:2001;582-586
102. Montgomery D, Goldberg J, Amar M, et al. Effects of hyperbaric oxygen therapy on children with spastic diplegic cerebral palsy: a pilot project. Undersea Hyperb Med. 26:1999;235-242
103. Hardy P, Collet JP, Goldberg J, et al. Neuropsychological effects of hyperbaric oxygen therapy in cerebral palsy. Dev Med Child Neurol. 44:2002;436-446
104. Albright AL. Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol. 11:(suppl 1):1996;S29-S35
105. Albright AL, Barry MJ, Fasick MP, Janosky J. Effects of continuous intrathecal baclofen infusion and selective posterior rhizotomy on upper extremity spasticity. Pediatr Neurosurg. 23:1995;82-85
106. Mason C, Gilpin P, McGowan S, Rossiter D. The effect of intrathecal baclofen on functional intelligibility of speech. Int J Lang Commun Disord. 33 (suppl):1998;24-25
107. Khalili AA, Harmel MH, Forster S, Benton JG. Management of spasticity by selective peripheral nerve block with dilute phenol solutions in clinical rehabilitation. Arch Phys Med Rehabil. 45:1964;513-519
108. Mooney V, Frykman G, McLamb J. Current status of intraneural phenol injections. Clin Orthop Rel Res. 63:1969;122-131
109. Moore TJ, Anderson RB. The use of open phenol blocks to the motor branches of the tibial nerve in adult acquired spasticity. Foot Ankle. 11:1991;219-221
110. Carpenter EB, Seitz DG. Intramuscular alcohol as an aid in management of spastic cerebral palsy. Dev Med Child Neurol. 22:1980;497-501
111. Carpenter EB. Role of nerve blocks in the foot and ankle in cerebral palsy: therapeutic and diagnostic. Foot Ankle. 4:1983;164-166
112. Tardieu G, Tardieu C, Hariga J. [Infiltrations with 45 degrees ethyl alcohol of the motor points, the roots by the epidural route, or of the posterior tibial nerve: their indications and contra-indications in the various forms of spasticity (experience of 10 years)] Rev Neurol (Paris) 1971; 125: 63-68.
113. Tardieu G, Tardieu C, Hariga J. Selective partial denervation by alcohol injections and their results in spasticity. Reconstr Surg Traumatol. 13:1972;18-36
114. Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 285:2001;1059-1070
115. Koman LA, Mooney JF, III, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop 1993; 13: 489-95.
116. Bakheit AM, Severa S, Cosgrove A, et al. Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity. Dev Med Child Neurol. 43:2001;234-238
117. Gormley ME, Gaebler-Spira D, Delgado MR. Use of botulinum toxin type A in pediatric patients with cerebral palsy: a three-center retrospective chart review. J Child Neurol. 16:2001;113-118
118. Baker R, Jasinski M, Maciag-Tymecka I, et al. Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study. Dev Med Child Neurol. 44:2002;666-675
119. Barwood S, Ballieu C, Boyd R, et al. Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Dev Med Child Neurol. 42:2000;116-121
120. Corry IS, Cosgrove AP, Walsh EG, McClean D, Graham HK. Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Dev Med Child Neurol. 39:1997;185-193
121. Koman LA, Mooney JF, III, Smith BP, Walker F, Leon JM. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. J Pediatr Orthop 2000; 20: 108-15.
122. Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG, Mubarak SJ. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture. 10:1999;1-9
123. Ubhi T, Bhakta BB, Ives HL, Allgar V, Roussounis SH. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child. 83:2000;481-487
124. Fehlings D, Rang M, Glazier J, Steele C. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr. 137:2000;331-337
125. Wissel J, Heinen F, Schenkel A, et al. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment. Neuropediatrics. 30:1999;120-124
126. Polak F, Morton R, Ward C, Wallace WA, Doderlein L, Siebel A. Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy. Dev Med Child Neurol. 44:2002;551-555
127. Corry IS, Cosgrove AP, Duffy CM, McNeill S, Taylor TC, Graham HK. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial. J Pediatr Orthop. 18:1998;304-311
128. Flett PJ, Stern LM, Waddy H, Connell TM, Seeger JD, Gibson SK. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. J Paediatr Child Health. 35:1999;71-77
129. Desloovere K, Molenaers G, Jonkers I, et al. A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures. Eur J Neurol. 8:(suppl 5):2001;75-87
130. Detrembleur C, Lejeune TM, Renders A, Van Den Bergh PY. Botulinum toxin and short-term electrical stimulation in the treatment of equinus in cerebral palsy. Mov Disord. 17:2002;162-169
131. Boyd RN, Dobson F, Parrott J, et al. The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: a randomized controlled trial. Eur J Neurol. 8:(suppl 5):2001;109-119
132. Koman LA, Brashear A, Rosenfeld S, et al. Botulinum toxin type A neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics. 108:2001;1062-1071
133. Wong V. Use of botulinum toxin injection in 17 children with spastic cerebral palsy. Pediatr Neurol. 18:1998;124-131
134. Jongerius PH, Rotteveel JJ, van den Hoogen F, Joosten F, van Hulst K, Gabreels FJ. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy: presentation of a case series. Eur J Pediatr. 160:2001;509-512
135. Arens LJ, Leary PM, Goldschmidt RB. Experience with botulinum toxin in the treatment of cerebral palsy. S Afr Med J. 87:1997;1001-1003
136. Peacock WJ, Eastman RW. The neurosurgical management of spasticity. S Afr Med J. 60:1981;849-850
137. Park TS, Owen JH. Surgical management of spastic diplegia in cerebral palsy. N Engl J Med. 326:1992;745-749
138. Park TS, Vogler GP, Phillips LH II, et al. Effects of selective dorsal rhizotomy for spastic diplegia on hip migration in cerebral palsy. Pediatr Neurosurg. 20:1994;43-49
139. Steinbok P, Reiner AM, Beauchamp R, Armstrong RW, Cochrane DD, Kestle J. A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy. Dev Med Child Neurol. 39:1997;178-184
140. McLaughlin J, Bjornson K, Temkin N, et al. Selective dorsal rhizotomy: meta-analysis of three randomized controlled trials. Dev Med Child Neurol. 44:2002;17-25
141. Chicoine MR, Park TS, Kaufman BA. Selective dorsal rhizotomy and rates of orthopedic surgery in children with spastic cerebral palsy. J Neurosurg. 86:1997;34-39
142. Greene WB, Dietz FR, Goldberg MJ, Gross RH, Miller F, Sussman MD. Rapid progression of hip subluxation in cerebral palsy after selective posterior rhizotomy. J Pediatr Orthop. 11:1991;494-497
143. Boscarino LF, Ounpuu S, Davis RB, III, Gage JR, DeLuca PA. Effects of selective dorsal rhizotomy on gait in children with cerebral palsy. J Pediatr Orthop 1993; 13: 174-79.
144. Mooney JF, III, Millis MB. Spinal deformity after selective dorsal rhizotomy in patients with cerebral palsy. Clin Orthop 1999; 364: 48-52.
145. Graham HK, Fixsen JA. Lengthening of the calcaneal tendon in spastic hemiplegia by the White slide technique. J Bone Joint Surg. 70B:1988;472-475
146. Reimers J. The stability of the hip in children: a radiological study of the results of muscle surgery in cerebral palsy. Acta Orthop Scand Suppl. 184:1980;1-100
147. Madigan RR, Wallace SL. Scoliosis in the institutionalized cerebral palsy population. Spine. 6:1981;583-589
148. Thomson JD, Banta JV. Scoliosis in cerebral palsy: an overview and recent results. J Pediatr Orthop B. 10:2001;6-9
149. Ferguson RL, Allen BL Jr. Considerations in the treatment of cerebral palsy patients with spinal deformities. Orthop Clin North Am. 19:1988;419-425
150. Thometz JG, Simon SR. Progression of scoliosis after skeletal maturity in institutionalized adults who have cerebral palsy. J Bone Joint Surg. 70A:1988;1290-1296
151. Sarwahi V, Sarwark JF, Schafer MF, et al. Standards in anterior spine surgery in pediatric patients with neuromuscular scoliosis. J Pediatr Orthop. 21:2001;756-760
152. Ginsberg GM, Lauder AJ. Progression of scoliosis in spastic quadriplegic patients after the insertion of an intrathecal baclofen pump. Dev Med Child Neurol. 44:(suppl 91):2002;13-14
153. Van Heest AE, House JH, Cariello C. Upper extremity surgical treatment of cerebral palsy. J Hand Surg. 24A:1999;323-330
154. Manske PR. Cerebral palsy of the upper extremity. Hand Clin. 6:1990;697-709
155. Nylander G, Carlstrom C, Adolfsson L. 4.5 year follow-up after surgical correction of upper extremity deformities in spastic cerebral palsy. J Hand Surg [Br]. 24:1999;719-723
156. Szabo RM, Gelberman RH. Operative treatment of cerebral palsy. Hand Clin. 1:1985;525-543
157. Koman LA, Gelberman RH, Toby BE, Poehling GG. Cerebral palsy; management of the upper extremity. Clin Orthop. 253:1990;62-74
158. Goldner JL, Koman LA, Gelberman R, Levin S, Goldner RD. Arthrodesis of the metacarpophalangeal joint of the thumb in children and adults: adjunctive treatment of thumb-in-palm deformity in cerebral palsy. Clin Orthop. 253:1990;75-89
159. Cooper J, Majnemer A, Rosenblatt B, Birnbaum R. The determination of sensory deficits in children with hemiplegic cerebral palsy. J Child Neurol. 10:1995;300-309
160. Mittal S, Farmer JP, Al Atassi B, et al. Impact of selective posterior rhizotomy on fine motor skills: long-term results using a validated evaluative measure. Pediatr Neurosurg. 36:2002;133-141
161. Gu Y, Wang T, Cai P, Shen L. Division of C8 nerve root for treatment of spastic cerebral palsy in the upper limbs: a preliminary report. Chin Med J (Engl). 111:1998;874-876
162. Goldner JL. Surgical reconstruction of the upper extremity in cerebral palsy. Hand Clin. 4:1988;223-265
163. Manske PR, Langewisch KR, Strecker WB, Albrecht MM. Anterior elbow release of spastic elbow flexion deformity in children with cerebral palsy. J Pediatr Orthop. 21:2001;772-777
164. Strecker WB, Emanuel JP, Dailey L, Manske PR. Comparison of pronator tenotomy and pronator rerouting in children with spastic cerebral palsy. J Hand Surg. 13A:1988;540-543
165. Van Heest AE, Sathy M, Schutte L. Cadaveric modeling of the pronator teres rerouting tendon transfer. J Hand Surg. 24:1999;614-618
166. El Said NS. Selective release of the flexor origin with transfer of flexor carpi ulnaris in cerebral palsy. J Bone Joint Surg Br. 83:2001;259-262
167. Pinzur MS. Flexor origin release and functional prehension in adult spastic hand deformity. J Hand Surg [Br]. 16:1991;133-136
168. Hoffer MM, Lehman M, Mitani M. Long-term follow-up on tendon transfers to the extensors of the wrist and fingers in patients with cerebral palsy. J Hand Surg. 11A:1986;836-840
169. Mowery CA, Gelberman RH, Rhoades CE. Upper extremity tendon transfers in cerebral palsy: electromyographic and functional analysis. J Pediatr Orthop. 5:1985;69-72
170. Filler BC, Stark HH, Boyes JH. Capsulodesis of the metacarpophalangeal joint of the thumb in children with cerebral palsy. J Bone Joint Surg. 58A:1976;667-670
171. Matev I. Surgery of the spastic thumb-in-palm deformity. J Hand Surg [Br]. 16:1991;127-132
172. Borton DC, Walker K, Pirpiris M, Nattrass GR, Graham HK. Isolated calf lengthening in cerebral palsy: outcome analysis of risk factors. J Bone Joint Surg Br. 83:2001;364-370
173. Doute DA, Sponseller PD, Tolo VT, Atkins E, Silberstein CE. Soleus neurectomy for dynamic ankle equinus in children with cerebral palsy. Am J Orthop. 26:1997;613-616
174. Fulford GE. Surgical management of ankle and foot deformities in cerebral palsy. Clin Orthop. 253:1990;55-61
175. Koman LA, Mooney JF3, Goodman A. Management of valgus hindfoot deformity in pediatric cerebral palsy patients by medial displacement osteotomy. J Pediatr Orthop. 13:1993;180-183
176. Andreacchio A, Orellana CA, Miller F, Bowen TR. Lateral column lengthening as treatment for planovalgus foot deformity in ambulatory children with spastic cerebral palsy. J Pediatr Orthop. 20:2000;501-505
177. Mosca VS. Calcaneal lengthening for valgus deformity of the hindfoot: results in children who had severe, symptomatic flatfoot and skewfoot. J Bone Joint Surg Am. 77:1995;500-512
178. Alman BA, Craig CL, Zimbler S. Subtalar arthrodesis for stabilization of valgus hindfoot in patients with cerebral palsy. J Pediatr Orthop. 13:1993;634-641
179. Drvaric DM, Schmitt EW, Nakano JM. The Grice extra-articular subtalar arthrodesis in the treatment of spastic hindfoot valgus deformity. Dev Med Child Neurol. 31:1989;665-669
180. Green NE, Griffin PP, Shiavi R. Split posterior tibial-tendon transfer in spastic cerebral palsy. J Bone Joint Surg Am. 65:1983;748-754
181. Kay RM, Rethlefsen SA, Skaggs D, Leet A. Outcome of medial versus combined medial and lateral hamstring lengthening surgery in cerebral palsy. J Pediatr Orthop. 22:2002;169-172
182. Beals RK. Treatment of knee contracture in cerebral palsy by hamstring lengthening, posterior capsulotomy, and quadriceps mechanism shortening. Dev Med Child Neurol. 43:2001;802-805
183. Chambers H, Lauer A, Kaufman K, Cardelia JM, Sutherland D. Prediction of outcome after rectus femoris surgery in cerebral palsy: the role of cocontraction of the rectus femoris and vastus lateralis. J Pediatr Orthop. 18:1998;703-711
184. Miller F, Cardoso DR, Lipton GE, Albarracin JP, Dabney KW, Castagno P. The effect of rectus EMG patterns on the outcome of rectus femoris transfers. J Pediatr Orthop. 17:1997;603-607
185. Elmer EB, Wenger DR, Mubarak SJ, Sutherland DH. Proximal hamstring lengthening in the sitting cerebral palsy patient. J Pediatr Orthop. 12:1992;329-336
186. DeLuca PA, Ounpuu S, Davis RB, Walsh JH. Effect of hamstring and psoas lengthening on pelvic tilt in patients with spastic diplegic cerebral palsy. J Pediatr Orthop. 18:1998;712-718
187. Cottalorda J, Gautheron V, Metton G, Charmet E, Maatougui K, Chavrier Y. Predicting the outcome of adductor tenotomy. Int Orthop. 22:1998;374-379
188. Novacheck TF, Trost JP, Schwartz MH. Intramuscular psoas lengthening improves dynamic hip function in children with cerebral palsy. J Pediatr Orthop. 22:2002;158-164
189. Root L, Spero CR. Hip adductor transfer compared with adductor tenotomy in cerebral palsy. J Bone Joint Surg Am. 63:1981;767-772
190. Flynn JM, Miller F. Management of hip disorders in patients with cerebral palsy. J Am Acad Orthop Surg. 10:2002;198-209